CRKL and chronic myelogenous leukemia, BCR-ABL1 positive: Our results indicated that CRKL was highly expressed in CML, the expression level of CRKL was decreased after CR of CML patients which played a crucial role in the development and progression of CML, it might be a potential diagnostic and therapeutic biomarker for CML.